Nov 16, 2022 / 06:00PM GMT
Jacob K. Johnson - Stephens Inc., Research Division - MD & Analyst
All right. Good afternoon, I guess now everybody. Welcome to Day 2 of the Stephens conference. I'm Jacob Johnson, the Life Science Tools and Pharma Services Analyst here at Stephens. Really excited to be joined today by Azenta, which I think as it happens 1-year anniversary of announcing the Azenta brand today. So -- it was exciting to talk about last year and some exciting things to talk about today.
We've got CEO, Steve Schwartz; CFO, Lindon Robertson; Sara Silverman from IR who is hanging out in the back, along with Vandana Sriram, the Controller of Azenta. So with that, I will turn it over to Steve or Lindon or both for any opening remarks.
Lindon G. Robertson - Azenta, Inc. - Executive VP & CFO
Great. So let me just start off with an overview of our company now. We just finished our fiscal year, and so it's a good time to kind of recapture and as Jacob just highlight, we've been now 1 year into wearing the Azenta name as a stand-alone life science company. Makes us a bit
Azenta Inc at Stephens Investment Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot